Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Gesval S A currently has 4 pending office actions within the Chemistry & Materials technology area. These actions are distributed among 4 distinct examiners, which means each pending matter is being reviewed by a different official. Furthermore, the prosecution is active across 4 distinct art units, indicating a broad technical footprint within the chemical and materials sectors. This high level of diversification requires the legal team to manage four separate sets of technical and procedural requirements.
The busiest examiner, WASHINGTON, BRITNEY NICOLE, is responsible for 1 pending office action. This matches the workload of the other three examiners, as the 4 total actions are evenly split. With 1 busiest examiner pending action, the company faces a decentralized prosecution environment. This requires the legal team to coordinate responses across four different art units and four different examiners, necessitating a versatile strategy to handle the specific requirements of each distinct official. Monitoring the 4 distinct examiners will be crucial for identifying the most efficient paths to allowance across the chemistry portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WASHINGTON, BRITNEY NICOLE | 1 | 84.0% | +13.2% |
| MCGUIRK, JOHN SCHUYLER | 1 | 77.8% | +49.3% |
| SHELTON, SYNPHANE LA'SHAWN | 1 | 100.0% | +0.0% |
| SULLIVAN, STEPHANIE LAUREN | 1 | 57.1% | +38.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694237 | CASSETTE CONFIGURED TO CONTAIN A MICROFLUIDIC CHIP | WASHINGTON, BRITNEY NICOLE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17904641 | DEPLETION OF EXT1 EXPRESSION AND/OR ACTIVITY IMPROVES CELLULAR PRODUCTION OF BIOLOGICAL ENTITIES | SULLIVAN, STEPHANIE LAUREN | 67d overdue |
| 18694002 | ACCESSORY FOR A PLATE OF A MICROFLUIDIC EXPERIMENTATION DEVICE, AND MICROFLUIDIC EXPERIMENTATION DEVICE | MCGUIRK, JOHN SCHUYLER | — |
| 18291332 | CELL-FREE TRNA FRAGMENT-BASED TR-FRET SCREENING AND COMPETITION ASSAY FOR INHIBITORS OF HUMAN TRNA MODIFICATION ENZYMES USEFUL IN THE PREVENTION OR TREATMENT OF TRNA MODIFICATION RELATED CONDITIONS | SHELTON, SYNPHANE LA'SHAWN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17904641 | DEPLETION OF EXT1 EXPRESSION AND/OR ACTIVITY IMPROVES CELLULAR PRODUCTION OF BIOLOGICAL ENTITIES | SULLIVAN, STEPHANIE LAUREN | 67d overdue |
| 18694237 | CASSETTE CONFIGURED TO CONTAIN A MICROFLUIDIC CHIP | WASHINGTON, BRITNEY NICOLE | — |
| 18694002 | ACCESSORY FOR A PLATE OF A MICROFLUIDIC EXPERIMENTATION DEVICE, AND MICROFLUIDIC EXPERIMENTATION DEVICE | MCGUIRK, JOHN SCHUYLER | — |
| Art Unit | Apps |
|---|---|
| 1797 | 1 |
| 1798 | 1 |
| 1652 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18694237 | CASSETTE CONFIGURED TO CONTAIN A MICROFLUIDIC CHIP | WASHINGTON, BRITNEY NICOLE | 1797 | §103 | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18694002 | ACCESSORY FOR A PLATE OF A MICROFLUIDIC EXPERIMENTATION DEVICE, AND MICROFLUIDIC EXPERIMENTATION DEVICE | MCGUIRK, JOHN SCHUYLER | 1798 | §102§103§112 | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18291332 | CELL-FREE TRNA FRAGMENT-BASED TR-FRET SCREENING AND COMPETITION ASSAY FOR INHIBITORS OF HUMAN TRNA MODIFICATION ENZYMES USEFUL IN THE PREVENTION OR TREATMENT OF TRNA MODIFICATION RELATED CONDITIONS | SHELTON, SYNPHANE LA'SHAWN | 1652 | §103§112 | Non-Final OA | — | Pending | Jan 23, 2024 |
| 17904641 | DEPLETION OF EXT1 EXPRESSION AND/OR ACTIVITY IMPROVES CELLULAR PRODUCTION OF BIOLOGICAL ENTITIES | SULLIVAN, STEPHANIE LAUREN | 1635 | §103§112 | Final Rejection | 67d overdue | Pending | Aug 19, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGesval S A has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Britney Nicole Washington has the most, with 1 of Gesval S A's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
